ABSTRACT
BACKGROUND: The most important principle in treating secretory otitis media (SOM) is ventilation of the tympanic cavity. CO2 laser myringotomy achieves this via a self-healing perforation whose diameter essentially determines the duration of transtympanic ventilation. PATIENTS, METHODS: In this study, laser myringotomy was performed with the CO2 laser otoscope Otoscan in a homogeneous patient collective comprising 81 children (159 ears) suffering from SOM. The tympanic intervention was combined with an adenoidectomy or a CO2 laser tonsillotomy and therefore performed under general insufflation anesthesia. In all ears, approximately 2 mm circular perforations were created in the lower anterior quadrants with a power of 12-15 W and a pulse duration of 180 ms. RESULTS: None of the children showed postoperative impairment of inner ear function. Otomicroscopic and videoendoscopic monitoring documented the healing process. The mean closure time was found to be 16.35 days (8-34 days). As a rule, an onion-skin-like membrane of keratinized material was seen in the former myringotomy perforations at the time of closure. At the follow-up 6 months later the laser myringotomy sites appeared normal and irritation-free. Two of the tympanic membranes (1.6%) examined showed atrophic scar formation, one (0.8%) a perforation with a diameter of 0.5 mm. In 19 ears (14.7%) there was a recurrence of SOM within the observation period. CONCLUSIONS: Laser myringotomy competes with ventilation tube insertion in the treatment of SOM. It may be an useful alternative in the surgical management of secretory otitis media.
Subject(s)
Middle Ear Ventilation/instrumentation , Otitis Media with Effusion/surgery , Otoscopes , Child , Child, Preschool , Equipment Design , Female , Follow-Up Studies , Humans , Image Processing, Computer-Assisted/instrumentation , Infant , Male , Recurrence , Time Factors , Video Recording/instrumentation , Wound Healing/physiologyABSTRACT
BACKGROUND AND OBJECTIVE: Laserotoscopes are suitable for low-pain outpatient surgery of otitis media with effusion (OME) under topical anesthesia. The myringotomy perforations should have a diameter greater than 2 mm to ventilate the middle ear for approximately 3 weeks. PATIENTS/METHODS: In this study, the clinical applicability of a prototype of an Er:YAG laserotoscope (Baasel Lasertechnik, Starnberg, Germany) was tested. Formalin-fixed human tympanic membranes yielded the parameters suitable for clinical application of an Er:YAG laserotoscope in patients. With a focussed laser beam (beam diameter 500 microns), one is able to achieve perforations of 50-micron diameter with one single laser pulse applying pulse energies of 70 mJ (energy density 36 J/cm2). The ablation rate, i.e., the tissue layer that is ablated per laser pulse, is 100 microns using pulse energies of 70 mJ. This means that formalin-fixed human tympanic membrane can be perforated with one single laser pulse. RESULTS: Ten patients with OME (otitis media with effusion) were treated under topical anesthesia of the tympanic membrane (8% tetracainbase in Isopropanol for 15 min) with focussed laser pulses (beam diameter 500 microns) with energies of 100 mJ (energy density 52 J/cm2). A sufficient perforation diameter of 2 mm could be achieved with an average of 15 juxtaposed laser applications. The enlargement of the perforations was made difficult by extruding middle ear secretions and slight bleeding of the tympanic membrane. Between laser applications, the target tissue had to be cleaned by suctioning using the operation microscope. The healing of the tympanic membrane was verified and compared in postoperative clinical follow-ups. With a perforation diameter of 2 mm, the Er:YAG laser myringotomies healed within 14 days. The used parameters did not generate side effects such as inner ear hearing loss. CONCLUSIONS: An effective, easy, and practical performance of laser myringotomy is not currently possible with the Er:YAG laserotoscope.
